Author:
Fukumoto Atsushi,Kim Yong-Pil,Iwatsuki Masato,Hirose Tomoyasu,Sunazuka Toshiaki,Hanaki Hideaki,Ōmura Satoshi,Shiomi Kazuro
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference12 articles.
1. Diep, B. A. & Otto, M. The role of virulence determinants in community-associated MRSA pathogenesis. Trends Microbiol. 16, 361–369 (2008).
2. Fukumoto, A. et al. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation. J. Antibiot. 61, 1–6 (2008).
3. Fukumoto, A. et al. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities. J. Antibiot. 61, 7–10 (2008).
4. Ōmura, S. et al(Kitasato Institute, Japan; Kyowa Hakko Kirin Co., Ltd., Japan) KB-3346-5 substances, their fermentative manufacture, and antibacterial agents containing them. Jpn Kokai Tokkyo Koho JP2009046404A (2009).
5. Fukumoto, A. et al. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities. J. Antibiot. (doi:10.1038/ja.2017.28).
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献